These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7863302)

  • 21. Persistent airways disease caused by toluene diisocyanate.
    Moller DR; McKay RT; Bernstein IL; Brooks SM
    Am Rev Respir Dis; 1986 Jul; 134(1):175-6. PubMed ID: 3014935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated interleukin-4 and interleukin-6 in rats sensitized with toluene diisocyanate.
    Zheng KC; Nong DX; Morioka T; Todoriki H; Ariizumi M
    Ind Health; 2001 Oct; 39(4):334-9. PubMed ID: 11758997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma.
    Park H; Jung K; Kim H; Nahm D; Kang K
    Clin Exp Allergy; 1999 Oct; 29(10):1395-401. PubMed ID: 10520061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
    Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM
    Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate.
    Moscato G; Dellabianca A; Corsico A; Biscaldi G; Gherson G; Vinci G
    Chest; 1993 Oct; 104(4):1127-32. PubMed ID: 8404179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
    Choi JH; Nahm DH; Kim SH; Kim YS; Suh CH; Park HS; Ahn SW
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):293-8. PubMed ID: 15478392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS; Nahm DH
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is occupational asthma to diisocyanates a non-IgE-mediated disease?
    Jones MG; Floyd A; Nouri-Aria KT; Jacobson MR; Durham SR; Taylor AN; Cullinan P
    J Allergy Clin Immunol; 2006 Mar; 117(3):663-9. PubMed ID: 16522468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate.
    Saetta M; Di Stefano A; Maestrelli P; De Marzo N; Milani GF; Pivirotto F; Mapp CE; Fabbri LM
    Am Rev Respir Dis; 1992 Jan; 145(1):160-8. PubMed ID: 1309963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late, but not early, asthmatic reactions induced by toluene-diisocyanate are associated with increased airway responsiveness to methacholine.
    Mapp CE; Di Giacomo GR; Omini C; Broseghini C; Fabbri LM
    Eur J Respir Dis; 1986 Oct; 69(4):276-84. PubMed ID: 3028853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDI-induced oculorhinitis and bronchial asthma.
    Paggiaro PL; Rossi O; Lastrucci L; Pardi F; Pezzini A; Baschieri L
    J Occup Med; 1985 Jan; 27(1):51-2. PubMed ID: 2982003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupational asthma caused by a prepolymer but not the monomer of toluene diisocyanate (TDI).
    Vandenplas O; Cartier A; Lesage J; Perrault G; Grammer LC; Malo JL
    J Allergy Clin Immunol; 1992 Jun; 89(6):1183-8. PubMed ID: 1318888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.
    Mapp CE; Boschetto P; Zocca E; Milani GF; Pivirotto F; Tegazzin V; Fabbri LM
    Bull Eur Physiopathol Respir; 1987; 23(6):583-6. PubMed ID: 2840139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure.
    Pisati G; Baruffini A; Zedda S
    Br J Ind Med; 1993 Jan; 50(1):60-4. PubMed ID: 8381658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study.
    Kopferschmitt-Kubler MC; Frossard N; Rohde G; Pauli G
    Respir Med; 1998 Sep; 92(9):1093-8. PubMed ID: 9926161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.
    Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR
    Am J Respir Crit Care Med; 1996 Feb; 153(2):551-6. PubMed ID: 8564096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma].
    Marabini A; Brugnami G; Curradi F; Severini C; Siracusa A
    Med Lav; 1994; 85(2):134-41. PubMed ID: 8072441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse.
    Scheerens H; Buckley TL; Davidse EM; Garssen J; Nijkamp FP; Van Loveren H
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):858-65. PubMed ID: 8887575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI).
    Mapp CE; Corona PC; De Marzo N; Fabbri L
    Am Rev Respir Dis; 1988 Jun; 137(6):1326-9. PubMed ID: 2849330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late asthmatic reactions, airway inflammation and chronic asthma in TDI sensitized subjects.
    Fabbri LM; Picotti G; Mapp CE
    Eur Respir J Suppl; 1991 Apr; 13():136s-138s. PubMed ID: 1659425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.